Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Prostatic Hyperplasia 1Pheochromocytoma 1Paraganglioma 1Lower Urinary Tract Symptoms 1

Interventions

3-Iodobenzylguanidine 3cabozantinib 2tipifarnib 1pembrolizumab 1pazopanib 1lutetium Lu 177 dotatate 1lenvatinib 1guadecitabine 1fostamatinib 1copper dotatate CU-64 1atezolizumab 1Temozolomide 1Surgical Procedures, Operative 1Sunitinib 1Phenoxybenzamine 1Nivolumab 1Lutetium-177 1Lutetium 1Iodine-131 1Everolimus 1Erlotinib Hydrochloride 1Doxazosin 1Capecitabine 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pheochromocytoma × Doxazosin × Clear all
NCT03176693 2023-11-20

Preoperative Alpha Blockade for Pheochromocytoma

University of California, Los Angeles

Phase 3 Completed
39 enrolled 8 charts
CNSEndocrine

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡